telmisartan has been researched along with Diabetic Cardiomyopathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaikwad, AB; Malek, V | 1 |
| Kong, D; Liu, W; Wu, W | 1 |
| Chang, WT; Chen, ZC; Cheng, JT | 1 |
| Emre, M; Kavak, S; Unlugenc, H | 1 |
1 trial(s) available for telmisartan and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Female; Fibrosis; Humans; Longitudinal Studies; Male; Middle Aged; Myocardium; Myocytes, Cardiac; PPAR gamma; Prospective Studies; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Streptozocin; Telmisartan; Time Factors; Translational Research, Biomedical; Treatment Outcome; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2016 |
3 other study(ies) available for telmisartan and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy.
Topics: Acetylation; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drug Therapy, Combination; Fibrosis; Histone Acetyltransferases; Histones; Male; Myocytes, Cardiac; Neprilysin; Protease Inhibitors; Protein Processing, Post-Translational; Rats, Wistar; Signal Transduction; Telmisartan; Thiorphan; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Telmisartan alleviates inflammatory response and myocardial apoptosis in diabetic cardiomyopathy rats through TGF-β1/Smad signaling pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Chemokine CCL2; Collagen Type I; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Interleukin-2; Lymphotoxin-alpha; Myocardium; Random Allocation; Rats; Smad Proteins; Smad3 Protein; Telmisartan; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2021 |
The effects of telmisartan on mechanical responses of left ventricular papillary muscle in rats with streptozotocin-induced diabetes mellitus.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Heart Ventricles; Humans; Male; Myocardial Contraction; Papillary Muscles; Rats; Rats, Wistar; Streptozocin; Telmisartan | 2010 |